MRCP2-1195

MRCP2-1195

A 32-year-old woman with a history of Graves’ disease presents to the endocrinology clinic for follow-up. She underwent radioiodine treatment a year ago and has since remained clinically and biochemically euthyroid. Her initial symptoms of weight loss and insomnia have not recurred. Her GP ordered blood tests prior to the appointment, which revealed a TSH level of 2.6 and a free T4 level of 8.2mg/dl. The patient has recently discontinued oral contraceptive use and is planning to conceive. What is the most appropriate management plan?